Literature DB >> 12790494

[Accessibility to methadone substitution treatment: the role of a low-threshold program].

Michel Perreault1, Michel Rousseau, Céline Mercier, Pierre Lauzon, Carole Gagnon, Pierre Côté.   

Abstract

OBJECTIVE: To evaluate the accessibility to a Montreal low-threshold methadone program (Relais-Méthadone). This program is aimed at a marginalized population of heroin addicts who are injection drug users (IDU).
METHOD: The data (n = 141 clients) were collected during the first year of the program implementation with questionnaires administered by the programme workers.
RESULTS: Analysis of the characteristics of the clients revealed that the program does reach the target population. The program's clientele is characterized by long-time and frequent heroin use, unstable lifestyles, and the presence of numerous behaviours that put them at high risk for HIV transmission. The retention of clients in the program is very high (88%) within the first 30 days.
INTERPRETATION: These results demonstrate the importance and value of flexible intervention programs in reaching a marginalized clientele exposed to the HIV virus, who would not have access to regular programs characterized by restrictive selection criteria and limited availability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790494

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  5 in total

1.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

2.  [Treatment retention and evolution of clientele in a low threshold methadone substitution treatment program in Montreal].

Authors:  Michel Perreault; Marie-Christine Héroux; Noé Djawn White; Pierre Lauzon; Céline Mercier; Michel Rousseau
Journal:  Can J Public Health       Date:  2007 Jan-Feb

3.  Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.

Authors:  Sharon Stancliff; Herman Joseph; Chunki Fong; Terry Furst; Sandra D Comer; Perrine Roux
Journal:  J Addict Dis       Date:  2012

4.  The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; Suzanne Brissette; Jill Chettiar; Pascal Schneeberger; David C Marsh; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  J Urban Health       Date:  2008-08-29       Impact factor: 3.671

5.  Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco.

Authors:  Jamie Carter; Barry Zevin; Paula J Lum
Journal:  Addict Sci Clin Pract       Date:  2019-05-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.